The Psyence team shares details on our existing cultivation and harvesting operations in our federally-licensed cultivation facility in Lesotho, Southern Africa. Psyence (CSE:PSYG) is a life science biotechnology company, pioneering the use of natural psychedelics in the treatment of trauma and mental health disorders.
Psyence Group2022-01-14T09:19:11+02:00March 22, 2021|Psychedelic News, Investor Information|
Psyence Group Announces Cantheon Capital Private Placement
March 23, 2023 | 0 Comments
Psyence Signs Letter of Intent with Australian CRO iNGENū
January 9, 2023 | 0 Comments